Ocular Therapeutix Inc (OCUL)

EBITDA

-$284.59M

TTM · Period ending: · USD

OCUL logo

OCUL EBITDA

Latest reported-$284.59M
OCUL TTM EBITDA (-$12.47M → -$284.59M)
High-resolution chart · PNG

OCUL ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ocular Therapeutix Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-284,594,000
-274,246,000
-249,782,000
-233,538,000
-200,501,000
-176,354,000
-176,143,000
-155,923,000
-119,813,000
-98,227,000
-66,417,000
-55,510,000
-81,192,000
-79,671,000
-61,906,000
-50,302,000
-23,511,000
-13,208,000
2,540,000
-79,079,000
-93,552,000
-121,504,000
-146,095,000
-86,414,000
-93,308,000
-81,556,000
-77,741,000
-70,646,000
-68,201,000
-58,569,000
-55,953,000
-51,594,000
-52,175,000
-57,264,000
-59,869,000
-59,936,000
-54,296,000
-47,324,000
-42,309,000
-40,233,000
-42,259,000
-40,807,000
-37,443,000
-34,751,000
-30,547,000
-27,045,000
-26,977,000
-22,883,000
-19,443,000
-16,386,000
-12,472,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.